<DOC>
	<DOCNO>NCT02611128</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) common disorder mark hyperandrogenism , oligo-/anovulation , subfertility . The precise cause PCOS unclear , pathophysiology involves complex genetic environmental influence . Importantly , girl obesity HA , free testosterone ( T ) concentration highly variable group . Luteinizing hormone ( LH ) insulin concentration significant partial predictor free T girl obesity ; significant unexplained variability free T suggest additional factor contribute HA population . Abnormalities ovarian adrenal steroidogenesis likely contributor regard , abnormality difficult quantify . Recent Genome Wide Association Studies identify DENND1A PCOS susceptibility gene candidate . Preliminary vitro data strongly implicate DENND1A splice variant call DENND1A Variant 2 ( DENND1A.V2 ) contributor excessive theca cell androgen production PCOS . The investigator ' primary goal propose pilot study determine relationship urinary exosomal DENND1A.V2 mRNA free T concentration peripubertal girl . The investigator hypothesize urinary exosomal DENND1A.V2 mRNA quantity significant independent predictor peripubertal hyperandrogenemia . In study , investigator carefully phenotype peripubertal girl without hyperandrogenemia ( primarily form hormonal , maturational , anthropometric measurement ) addition measure urinary exosomal DENND1A.V2 mRNA . As primary analysis , investigator examine relationship morning free testosterone urinary exosomal DENND1A.V2 , control previously-described partial predictor free testosterone ( LH , insulin ) addition potential confounders ( BMI z-score , bone age ) . These study provide important information regard etiology HA peripubertal girl . Ultimately , data may lead non-invasive test ovarian/adrenal steroidogenic activity support development diagnostic test PCOS high-risk peripubertal girl ( e.g. , obesity ) .</brief_summary>
	<brief_title>Urinary DENND1A.V2 Predictor Pubertal Hyperandrogenemia</brief_title>
	<detailed_description>To date , mechanism underlie excess androgen production steroid produce tissue unclear , recent Genome Wide Association Studies ( GWAS ) provide additional data regard . Initial GWAS data Han Chinese population identify 12 loci potential PCOS susceptibility gene candidate . One locus , DENND1A locus 9q22.32 , replicate GWAS study Asian European population . Strauss colleague recently demonstrate DENND1A expression testis , ovarian theca cell , H295 adrenal carcinoma cell — androgen produce tissues/cells . DENND1A therefore exceedingly strong PCOS susceptibility gene candidate . However , remain unclear DENND1A may contribute PCOS phenotype . Importantly , two transcriptional form DENND1A gene — consequence alternate splicing . The large transcript ( DENND1A Variant 1 , DENND1A.V1 ) encode 1009 amino acid protein , small transcript DENND1A.V2 encode truncate 559 amino acid . The product DENND1A.V2 contain DENN domain clathrin-binding domain , differs product DENND1A.V1 two way : ( 1 ) contain proline-rich C-terminal domain present Variant 1 , ( 2 ) DENND1A.V2 result differential splice contains unique 33 amino acid C-terminal sequence . Of significant interest , publish study Drs . McAllister Strauss ( McAllister JM , et al . Proc Natl Acad Sci USA . 2014 ; 111 : E1519-27 ) strongly implicate DENND1A.V2 splice variant contributor excessive theca cell androgen production PCOS : - Expression DENND1A.V2 protein culture theca cell isolated woman PCOS 3-fold elevate compare normal ovarian theca cell . Similarly , DENND1A.V2 mRNA abundance elevate PCOS theca correlate increased theca cell androgen ( dehydroepiandrosterone [ DHEA ] ) production . - Forced expression DENND1A.V2 normal theca cell increase expression CYP17A1 CYP11A1 ( gene key steroidogenic enzyme ) along androgen/androgen precursor ( e.g. , 17OHP4 , DHEA , testosterone ) progesterone production . - Knockdown DENND1A.V2 culture PCOS theca cell reduce CYP17A1 CYP11A1 expression addition 17OHP4 DHEA production . - Treatment culture PCOS theca cell anti-DENND1A.V2 IgG antibody reduce expression CYP17A1 CYP11A1 mRNA expression well DHEA 17OHP4 synthesis . These data provide strong support contention DENND1A.V2 splice variant major factor underlie phenotype culture PCOS theca cell , thus , etiology ovarian hyperandrogenemia PCOS . By extension , DENND1A.V2 splice variant may significant contributor peripubertal hyperandrogenemia , may explain much variable hyperandrogenemia observe obese peripubertal girl . The investigator propose , peripubertal girl , increase expression DENND1A.V2 ovarian and/or adrenal cell promote excess androgen secretion advent puberty ( ovarian stimulation LH increase ) and/or presence obesity ( e.g. , enhanced insulin secretion , augment LH-stimulated ovarian androgen synthesis and/or ACTH-stimulated adrenal androgen synthesis ) . Of great interest , preliminary data 5 normal woman 6 woman PCOS suggest urinary exosomal DENND1A.V2 mRNA approximately 3-fold elevated woman PCOS compare normally-cycling control ( McAllister JM , et al . Proc Natl Acad Sci USA . 2014 ; 111 : E1519-27 ) . Exosomes small vesicle ( 40-100 nm ) contain nucleic acid shed cell blood urine , know stable source RNA . Thus , urinary exosomal DENND1A.V2 quantity may serve marker DENND1A.V2 activity ovary/adrenal . In proposed study , investigator ( include collaborator Drs . McAllister Strauss ) obtain urine exosomal DENND1A.V2 mRNA quantitation addition blood sample measure androgen level , LH insulin ( latter two previously-demonstrated predict free testosterone ) . The investigator test hypothesis quantity urinary exosomal DENND1A.V2 mRNA strong independent predictor androgen level peripubertal girl . To investigator ' knowledge , data exist tie PCOS susceptibility gene candidate pubertal hyperandrogenemia . The investigator propose evaluate novel biomarker ( urinary exosomal DENND1A.V2 mRNA ) predictor free testosterone pubertal girl . Evaluation biomarker adolescent highly innovative . The present proposal build Aim 3 Project 1 ( NIH P50 HD28934 ) , investigator carefully assess determinant hyperandrogenemia girl peripubertal obesity . Specifically , Aim 3 intensive protocol involve ( ) overnight frequent blood sample LH insulin along ( b ) ovarian adrenal stimulation protocol subsequent 2 day . Some subject participate propose pilot study also participate Aim 3 . Correlation urinary exosomal DENND1A.V2 mRNA ovarian/adrenal stimulation protocol allow preliminary assessment urinary exosomal DENND1A.V2 mRNA non-invasive measure ovarian/adrenal steroidogenesis — potentially important clinical tool . Peripubertal girl hyperandrogenemia believe high risk develop adolescent/adult PCOS , since manifestation PCOS overlap finding normal puberty , diagnosis PCOS may unreliable late adolescence . If urinary exosomal DENND1A.V2 mRNA significant predictor hyperandrogenemia cohort , future study determine utility urinary exosomal DENND1A.V2 diagnostic test predict development PCOS across puberty . This innovative exceedingly excite prospect may significant potential implication at-risk girl .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<criteria>List Inclusion Criteria • Peripubertal girl , Tanner breast stage 15 List Exclusion Criteria Age &lt; 8 &gt; 17 Men boy exclude Inability obtain proper consent/assent Atypical obesity Underweight : Underweight define BMIforage percentile &lt; 5 Positive pregnancy test lactation Assessment luteal phase suggest serum progesterone ≥ 1.5 ng/ml Virilization total testosterone &gt; 150 ng/dl Excessively elevate DHEAS : This define DHEAS &gt; 1.5 time ageappropriate upper limit normal Congenital adrenal hyperplasia ( CAH ) Cortisol deficiency/excess Inadequatelytreated unstable thyroid dysfunction Significant hyperprolactinemia : Since mild elevation may see girl hyperandrogenemia PCOS , elevations 30 ( i.e. , 1.5 time upper limit normal ) accept girl Significant chronic medical history : This include significant history cardiac pulmonary dysfunction ( e.g. , know suspect congestive heart failure ; asthma require intermittent systemic corticosteroid ; etc . ) ; history renal insufficiency durable electrolyte abnormality ; history substantial liver disease . A history liver test abnormality allow two circumstance : ( 1 ) mild bilirubin elevation accept set know Gilbert 's syndrome ; ( 2 ) mild transaminase ( ALT , AST ) elevation may see obese girl , stable elevation &lt; 1.5 time upper limit normal accept group . Uncontrolled type 2 diabetes mellitus : This reflect hemoglobin A1c &gt; 7.0 % . Subjects impair glucose tolerance diagnosis type 2 diabetes wellcontrolled lifestyle management alone allow participate . Type 1 diabetes mellitus : Since subject type 1 diabetes invariably require exogenous insulin , allow participate .</criteria>
	<gender>Female</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>